|
OMIM |
Link |
Information gain |
01 |
|
apnea, obstructive sleep
|
[NCBI]
|
0.00869109
|
|
|
hypertension, essential
|
[NCBI]
|
0.00543514
|
|
|
hypertension with brachydactyly
|
[NCBI]
|
0.00516716
|
|
|
NPPA
|
[NCBI]
|
0.00502862
|
|
|
hypertension, essential, susceptibility to, 1
|
[NCBI]
|
0.00281734
|
|
|
GRA
|
[NCBI]
|
0.00266084
|
|
|
PEE1
|
[NCBI]
|
0.00211532
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
0.00193301
|
|
|
ACE
|
[NCBI]
|
0.00169734
|
|
|
AVP
|
[NCBI]
|
0.00142997
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
0.00134288
|
|
|
PHA2
|
[NCBI]
|
0.000928292
|
|
|
creatinine clearance quantitative trait locus
|
[NCBI]
|
0.000702101
|
|
|
hypertension, essential, susceptibility to, 6
|
[NCBI]
|
0.000702101
|
|
|
peripheral arterial occlusive disease 1
|
[NCBI]
|
0.000702101
|
|
|
hypertension, essential, susceptibility to, 2
|
[NCBI]
|
0.000702101
|
|
|
hypertension, essential, susceptibility to, 5
|
[NCBI]
|
0.000702101
|
|
|
coronary heart disease, susceptibility to, 4
|
[NCBI]
|
0.000702101
|
|
|
hypertension, essential, susceptibility to, 3
|
[NCBI]
|
0.000702101
|
|
|
hypertension, essential, susceptibility to, 7
|
[NCBI]
|
0.000702101
|
|
|
hypertension, essential, susceptibility to, 4
|
[NCBI]
|
0.000702101
|
|
|
AGT
|
[NCBI]
|
0.000586529
|
|
|
renal failure, progressive, with hypertension
|
[NCBI]
|
0.000573544
|
|
|
NPY
|
[NCBI]
|
0.000565998
|
|
|
REN
|
[NCBI]
|
0.000508668
|
|
|
hyperaldosteronism, familial, type ii
|
[NCBI]
|
0.000485951
|
|
|
orthostatic hypotensive disorder, streeten type
|
[NCBI]
|
0.000485951
|
|
|
MAFD4
|
[NCBI]
|
0.000485951
|
|
|
liddle syndrome
|
[NCBI]
|
0.000480009
|
|
|
isoproterenol-mediated vasodilatation
|
[NCBI]
|
0.000436775
|
|
|
CMH
|
[NCBI]
|
0.000428107
|
|
|
CHDS8
|
[NCBI]
|
0.000405493
|
|
|
SCNN1B
|
[NCBI]
|
0.000401718
|
|
|
CF
|
[NCBI]
|
0.000370914
|
|
|
CELIAC6
|
[NCBI]
|
0.000353879
|
|
|
WNK4
|
[NCBI]
|
0.000342251
|
|
|
adrenal hyperplasia, congenital, due to steroid 11-beta-hydroxylase deficiency
|
[NCBI]
|
0.00032723
|
|
|
PTH
|
[NCBI]
|
0.000322689
|
|
|
KLK3
|
[NCBI]
|
0.000320388
|
|
|
laryngeal abductor paralysis
|
[NCBI]
|
0.000315963
|
|
|
AGTR1
|
[NCBI]
|
0.000305054
|
|
|
amyloidosis vi
|
[NCBI]
|
0.000280878
|
|
|
polycystic kidneys
|
[NCBI]
|
0.000277915
|
|
|
aneurysm, intracranial berry, 1
|
[NCBI]
|
0.000267227
|
|
|
WNK1
|
[NCBI]
|
0.000257668
|
|
|
cleidocranial dysplasia with micrognathia, absent thumbs, and distal aphalangia
|
[NCBI]
|
0.000240872
|
|
|
PNMT
|
[NCBI]
|
0.00022917
|
|
|
ADM
|
[NCBI]
|
0.00022619
|
|
|
AME2
|
[NCBI]
|
0.000225557
|
|
|
pseudohyperkalemia, familial, 1, due to red cell leak
|
[NCBI]
|
0.000222979
|
|
|
TNF
|
[NCBI]
|
0.000217093
|
|
|
ENPEP
|
[NCBI]
|
0.000202404
|
|
|
SLE
|
[NCBI]
|
0.000193751
|
|
|
IBD5
|
[NCBI]
|
0.000193348
|
|
|
CARASIL
|
[NCBI]
|
0.000193348
|
|
|
adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency
|
[NCBI]
|
0.000188287
|
|
|
RA
|
[NCBI]
|
0.000187496
|
|
|
MYMY1
|
[NCBI]
|
0.000169541
|
|
|
WBS
|
[NCBI]
|
0.000169485
|
|
|
EGFR
|
[NCBI]
|
0.000169228
|
|
|
CYP11B2
|
[NCBI]
|
0.000152619
|
|
|
CHGA
|
[NCBI]
|
0.000152619
|
|
|
CYP11B1
|
[NCBI]
|
0.000152619
|
|
|
ATP1A1
|
[NCBI]
|
0.000143965
|
|
|
resting heart rate
|
[NCBI]
|
0.00014371
|
|
|
SAH
|
[NCBI]
|
0.000136282
|
|
|
AFP
|
[NCBI]
|
0.000131423
|
|
|
CALCRL
|
[NCBI]
|
0.000127097
|
|
|
AR
|
[NCBI]
|
0.000122505
|
|
|
GNB3
|
[NCBI]
|
0.00011077
|
|
|
COMT
|
[NCBI]
|
0.000108059
|
|
|
DHS
|
[NCBI]
|
0.000106239
|
|
|
BBS
|
[NCBI]
|
0.000103582
|
|
|
pheochromocytoma
|
[NCBI]
|
0.000101205
|
|
|
IBGC1
|
[NCBI]
|
0.000100563
|
|
|
FPLD2
|
[NCBI]
|
9.97578e-05
|
|
|
PCNA
|
[NCBI]
|
9.65414e-05
|
|
|
NOS3
|
[NCBI]
|
9.479e-05
|
|
|
EGF
|
[NCBI]
|
9.45535e-05
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
9.4067e-05
|
|
|
MPO
|
[NCBI]
|
9.38407e-05
|
|
|
CYP4A11
|
[NCBI]
|
9.0848e-05
|
|
|
SCNN1G
|
[NCBI]
|
8.91754e-05
|
|
|
CD36
|
[NCBI]
|
8.90315e-05
|
|
|
hypertension, diastolic, resistance to
|
[NCBI]
|
8.72756e-05
|
|
|
hypertension, early-onset, autosomal dominant, with severe exacerbation in pregnancy
|
[NCBI]
|
8.72756e-05
|
|
|
tachycardia, hypertension, microphthalmia, and hyperglycinuria
|
[NCBI]
|
8.72756e-05
|
|
|
HYT8
|
[NCBI]
|
8.72756e-05
|
|
|
hypomagnesemia, hypertension, and hypercholesterolemia, mitochondrial
|
[NCBI]
|
8.72756e-05
|
|
|
osteochondrodysplasia, rhizomelic, with callosal agenesis, thrombocytopenia, hydrocephalus, and hypertension
|
[NCBI]
|
8.72756e-05
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
8.54656e-05
|
|
|
BDNF
|
[NCBI]
|
8.40264e-05
|
|
|
ADD1
|
[NCBI]
|
7.62816e-05
|
|
|
IGAN1
|
[NCBI]
|
7.27461e-05
|
|
|
NPR1
|
[NCBI]
|
7.19693e-05
|
|
|
RAMP2
|
[NCBI]
|
7.19693e-05
|
|
|
TH
|
[NCBI]
|
7.06498e-05
|
|
|
PPARG
|
[NCBI]
|
6.58093e-05
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
6.53376e-05
|
|
|
CRC
|
[NCBI]
|
6.52899e-05
|
|
|
LPL
|
[NCBI]
|
6.51818e-05
|
|
|
arterial occlusive disease, progressive, with hypertension, heart defects, bone fragility, and brachysyndactyly
|
[NCBI]
|
6.48774e-05
|
|
|
arcus corneae
|
[NCBI]
|
6.48774e-05
|
|
|
HSA
|
[NCBI]
|
6.48774e-05
|
|
|
anal sphincter myopathy, internal
|
[NCBI]
|
6.48774e-05
|
|
|
hyperostosis frontalis interna
|
[NCBI]
|
6.48774e-05
|
|
|
DRD1
|
[NCBI]
|
5.77074e-05
|
|
|
GPRK2L
|
[NCBI]
|
5.77074e-05
|
|
|
stroke, susceptibility to, 1
|
[NCBI]
|
5.64698e-05
|
|
|
longevity
|
[NCBI]
|
5.64698e-05
|
|
|
pheochromocytoma--islet cell tumor syndrome
|
[NCBI]
|
5.64698e-05
|
|
|
retinohepatoendocrinologic syndrome
|
[NCBI]
|
5.64698e-05
|
|
|
bilirubin, elevated concentrations of, in serum
|
[NCBI]
|
5.64698e-05
|
|
|
pulmonary hypertension, primary, autosomal recessive
|
[NCBI]
|
5.64698e-05
|
|
|
sodium-potassium-atpase activity of red cell
|
[NCBI]
|
5.64698e-05
|
|
|
NOS2A
|
[NCBI]
|
5.55572e-05
|
|
|
CAT
|
[NCBI]
|
5.54241e-05
|
|
|
EPO
|
[NCBI]
|
5.50898e-05
|
|
|
GCGR
|
[NCBI]
|
5.32976e-05
|
|
|
PPARA
|
[NCBI]
|
5.13287e-05
|
|
|
carotid intimal medial thickness 1
|
[NCBI]
|
5.10359e-05
|
|
|
pseudohyperkalemia cardiff
|
[NCBI]
|
5.10359e-05
|
|
|
CADASIL
|
[NCBI]
|
5.02515e-05
|
|
|
AIMAH
|
[NCBI]
|
4.79463e-05
|
|
|
earlobe crease
|
[NCBI]
|
4.70145e-05
|
|
|
cortisone reductase deficiency
|
[NCBI]
|
4.70145e-05
|
|
|
intracranial hypertension, idiopathic
|
[NCBI]
|
4.70145e-05
|
|
|
membranoproliferative glomerulonephritis, x-linked
|
[NCBI]
|
4.70145e-05
|
|
|
GUCY1A3
|
[NCBI]
|
4.54207e-05
|
|
|
PRCP
|
[NCBI]
|
4.54207e-05
|
|
|
MEX3C
|
[NCBI]
|
4.54207e-05
|
|
|
NHEDC2
|
[NCBI]
|
4.54207e-05
|
|
|
GUCY1B2
|
[NCBI]
|
4.54207e-05
|
|
|
RAMP1
|
[NCBI]
|
4.54207e-05
|
|
|
SLC14A2
|
[NCBI]
|
4.54207e-05
|
|
|
EMILIN1
|
[NCBI]
|
4.54207e-05
|
|
|
CPT1B
|
[NCBI]
|
4.54207e-05
|
|
|
PTGIS
|
[NCBI]
|
4.54207e-05
|
|
|
UQCRC2
|
[NCBI]
|
4.54207e-05
|
|
|
ATP1B1
|
[NCBI]
|
4.54207e-05
|
|
|
NPR3
|
[NCBI]
|
4.54207e-05
|
|
|
ATP5C1
|
[NCBI]
|
4.54207e-05
|
|
|
RGS2
|
[NCBI]
|
4.54207e-05
|
|
|
GPR91
|
[NCBI]
|
4.54207e-05
|
|
|
GUCY1B3
|
[NCBI]
|
4.54207e-05
|
|
|
GPR80
|
[NCBI]
|
4.54207e-05
|
|
|
CFTR
|
[NCBI]
|
4.46855e-05
|
|
|
GFAP
|
[NCBI]
|
4.46693e-05
|
|
|
FPLD3
|
[NCBI]
|
4.38249e-05
|
|
|
HOA
|
[NCBI]
|
4.38249e-05
|
|
|
TNFSF6
|
[NCBI]
|
4.35708e-05
|
|
|
SCNN1A
|
[NCBI]
|
4.19324e-05
|
|
|
AD
|
[NCBI]
|
4.06693e-05
|
|
|
aHUS
|
[NCBI]
|
3.82253e-05
|
|
|
IRS1
|
[NCBI]
|
3.78207e-05
|
|
|
CYP17A1
|
[NCBI]
|
3.78207e-05
|
|
|
XDH
|
[NCBI]
|
3.77416e-05
|
|
|
hyperlipidemia, combined, 1
|
[NCBI]
|
3.69786e-05
|
|
|
UCP2
|
[NCBI]
|
3.61312e-05
|
|
|
ADA
|
[NCBI]
|
3.56364e-05
|
|
|
hydrops-ectopic calcification-moth-eaten skeletal dysplasia
|
[NCBI]
|
3.52481e-05
|
|
|
HSD11B1
|
[NCBI]
|
3.50141e-05
|
|
|
HBB
|
[NCBI]
|
3.49322e-05
|
|
|
INS
|
[NCBI]
|
3.44221e-05
|
|
|
ESR2
|
[NCBI]
|
3.23711e-05
|
|
|
corticosterone methyloxidase type ii deficiency
|
[NCBI]
|
3.22976e-05
|
|
|
PRKCH
|
[NCBI]
|
3.17436e-05
|
|
|
SH2B3
|
[NCBI]
|
3.17436e-05
|
|
|
RENBP
|
[NCBI]
|
3.17436e-05
|
|
|
E2F2
|
[NCBI]
|
3.17436e-05
|
|
|
adipocyte-derived leucine aminopeptidase
|
[NCBI]
|
3.17436e-05
|
|
|
PTPN2
|
[NCBI]
|
3.17436e-05
|
|
|
NEDD4L
|
[NCBI]
|
3.17436e-05
|
|
|
hypertension-related calcium-regulated gene
|
[NCBI]
|
3.17436e-05
|
|
|
CETP
|
[NCBI]
|
3.00864e-05
|
|
|
HCHWAD
|
[NCBI]
|
2.9846e-05
|
|
|
drug metabolism, poor, cyp2d6-related
|
[NCBI]
|
2.9846e-05
|
|
|
chondrodysplasia punctata, autosomal dominant
|
[NCBI]
|
2.77546e-05
|
|
|
denys-drash syndrome
|
[NCBI]
|
2.77546e-05
|
|
|
CLEC16A
|
[NCBI]
|
2.66457e-05
|
|
|
ATG16L1
|
[NCBI]
|
2.66457e-05
|
|
|
ADD2
|
[NCBI]
|
2.66457e-05
|
|
|
ARF3
|
[NCBI]
|
2.66457e-05
|
|
|
SLC8A1
|
[NCBI]
|
2.66457e-05
|
|
|
KLK1
|
[NCBI]
|
2.66457e-05
|
|
|
KCNMB1
|
[NCBI]
|
2.66457e-05
|
|
|
INPPL1
|
[NCBI]
|
2.66457e-05
|
|
|
PLA2G1B
|
[NCBI]
|
2.66457e-05
|
|
|
CMA1
|
[NCBI]
|
2.66457e-05
|
|
|
RGS5
|
[NCBI]
|
2.66457e-05
|
|
|
ACHE
|
[NCBI]
|
2.57342e-05
|
|
|
EDN1
|
[NCBI]
|
2.54733e-05
|
|
|
DHFR
|
[NCBI]
|
2.53918e-05
|
|
|
PD
|
[NCBI]
|
2.51626e-05
|
|
|
SOST
|
[NCBI]
|
2.433e-05
|
|
|
PTK2B
|
[NCBI]
|
2.39493e-05
|
|
|
RTD
|
[NCBI]
|
2.35937e-05
|
|
|
CRHR2
|
[NCBI]
|
2.33714e-05
|
|
|
PPP1R12A
|
[NCBI]
|
2.33714e-05
|
|
|
PTGDS
|
[NCBI]
|
2.33714e-05
|
|
|
TRHR
|
[NCBI]
|
2.33714e-05
|
|
|
EDNRA
|
[NCBI]
|
2.33714e-05
|
|
|
NEDD4
|
[NCBI]
|
2.33714e-05
|
|
|
ACE2
|
[NCBI]
|
2.33714e-05
|
|
|
POMC
|
[NCBI]
|
2.31279e-05
|
|
|
GACI
|
[NCBI]
|
2.22333e-05
|
|
|
VEGF
|
[NCBI]
|
2.21669e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
2.19513e-05
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
2.1724e-05
|
|
|
acromegaly
|
[NCBI]
|
2.16028e-05
|
|
|
IGF2BP2
|
[NCBI]
|
2.09632e-05
|
|
|
ADORA2A
|
[NCBI]
|
2.09632e-05
|
|
|
IRGM
|
[NCBI]
|
2.09632e-05
|
|
|
CDKAL1
|
[NCBI]
|
2.09632e-05
|
|
|
PHA
|
[NCBI]
|
2.04276e-05
|
|
|
TTP
|
[NCBI]
|
2.04276e-05
|
|
|
SPS
|
[NCBI]
|
2.03049e-05
|
|
|
KAL2
|
[NCBI]
|
1.98785e-05
|
|
|
PAEP
|
[NCBI]
|
1.95832e-05
|
|
|
PF4
|
[NCBI]
|
1.94944e-05
|
|
|
CTGF
|
[NCBI]
|
1.92453e-05
|
|
|
PPIB
|
[NCBI]
|
1.90651e-05
|
|
|
CPT1A
|
[NCBI]
|
1.90651e-05
|
|
|
NCOA1
|
[NCBI]
|
1.90651e-05
|
|
|
MIRN155
|
[NCBI]
|
1.90651e-05
|
|
|
ERBB3
|
[NCBI]
|
1.90651e-05
|
|
|
GCCR
|
[NCBI]
|
1.85468e-05
|
|
|
NPHP1
|
[NCBI]
|
1.83633e-05
|
|
|
CAST
|
[NCBI]
|
1.75042e-05
|
|
|
XPNPEP2
|
[NCBI]
|
1.75042e-05
|
|
|
FKBP1B
|
[NCBI]
|
1.75042e-05
|
|
|
IL23R
|
[NCBI]
|
1.75042e-05
|
|
|
GYS1
|
[NCBI]
|
1.75042e-05
|
|
|
NPPB
|
[NCBI]
|
1.75042e-05
|
|
|
bartter syndrome, type 3
|
[NCBI]
|
1.74489e-05
|
|
|
PPSH
|
[NCBI]
|
1.74489e-05
|
|
|
AGER
|
[NCBI]
|
1.69752e-05
|
|
|
VHL
|
[NCBI]
|
1.67775e-05
|
|
|
HP
|
[NCBI]
|
1.6313e-05
|
|
|
MAP2K1
|
[NCBI]
|
1.61827e-05
|
|
|
CES1
|
[NCBI]
|
1.61827e-05
|
|
|
PTPRO
|
[NCBI]
|
1.61827e-05
|
|
|
PDE4D
|
[NCBI]
|
1.61827e-05
|
|
|
SELE
|
[NCBI]
|
1.61827e-05
|
|
|
ECE1
|
[NCBI]
|
1.61827e-05
|
|
|
kabuki syndrome
|
[NCBI]
|
1.53662e-05
|
|
|
RBS
|
[NCBI]
|
1.50694e-05
|
|
|
FSTL3
|
[NCBI]
|
1.50405e-05
|
|
|
USF1
|
[NCBI]
|
1.50405e-05
|
|
|
IDDM
|
[NCBI]
|
1.47336e-05
|
|
|
MTTI
|
[NCBI]
|
1.40372e-05
|
|
|
THBD
|
[NCBI]
|
1.40372e-05
|
|
|
DRD3
|
[NCBI]
|
1.40372e-05
|
|
|
ADRB1
|
[NCBI]
|
1.40372e-05
|
|
|
TLR4
|
[NCBI]
|
1.39003e-05
|
|
|
FMF
|
[NCBI]
|
1.35593e-05
|
|
|
VDR
|
[NCBI]
|
1.31789e-05
|
|
|
SEMA3A
|
[NCBI]
|
1.3145e-05
|
|
|
GJA4
|
[NCBI]
|
1.3145e-05
|
|
|
PGL1
|
[NCBI]
|
1.31104e-05
|
|
|
GNRH1
|
[NCBI]
|
1.26972e-05
|
|
|
WFS1
|
[NCBI]
|
1.25307e-05
|
|
|
IL6R
|
[NCBI]
|
1.23437e-05
|
|
|
CRHR1
|
[NCBI]
|
1.23437e-05
|
|
|
CYBA
|
[NCBI]
|
1.23437e-05
|
|
|
F3
|
[NCBI]
|
1.17245e-05
|
|
|
PGF
|
[NCBI]
|
1.16179e-05
|
|
|
CPT2
|
[NCBI]
|
1.16179e-05
|
|
|
PIK3CG
|
[NCBI]
|
1.16179e-05
|
|
|
MC2R
|
[NCBI]
|
1.16179e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
1.13261e-05
|
|
|
TGFB1
|
[NCBI]
|
1.11958e-05
|
|
|
G6PD
|
[NCBI]
|
1.0966e-05
|
|
|
CAV1
|
[NCBI]
|
1.0956e-05
|
|
|
FLT1
|
[NCBI]
|
1.0956e-05
|
|
|
ATP2A2
|
[NCBI]
|
1.0956e-05
|
|
|
CSA
|
[NCBI]
|
1.07326e-05
|
|
|
PTK2
|
[NCBI]
|
1.0669e-05
|
|
|
LCAT
|
[NCBI]
|
1.06283e-05
|
|
|
temporal arteritis
|
[NCBI]
|
1.05795e-05
|
|
|
SELP
|
[NCBI]
|
1.03489e-05
|
|
|
PPARGC1A
|
[NCBI]
|
1.03489e-05
|
|
|
NR3C2
|
[NCBI]
|
1.03489e-05
|
|
|
PTPN22
|
[NCBI]
|
1.03489e-05
|
|
|
PTPN1
|
[NCBI]
|
1.03489e-05
|
|
|
AHR
|
[NCBI]
|
1.00752e-05
|
|
|
RTS
|
[NCBI]
|
1.00554e-05
|
|
|
MDD
|
[NCBI]
|
1.0041e-05
|
|
|
GAL
|
[NCBI]
|
1.00217e-05
|
|
|
MMP1
|
[NCBI]
|
9.27114e-06
|
|
|
NCF1
|
[NCBI]
|
9.27114e-06
|
|
|
SLC12A3
|
[NCBI]
|
9.27114e-06
|
|
|
ARPKD
|
[NCBI]
|
9.02968e-06
|
|
|
CASR
|
[NCBI]
|
8.6381e-06
|
|
|
PTGS2
|
[NCBI]
|
8.58476e-06
|
|
|
SLC22A5
|
[NCBI]
|
8.34065e-06
|
|
|
LBR
|
[NCBI]
|
8.34065e-06
|
|
|
C4B
|
[NCBI]
|
8.34065e-06
|
|
|
MTCO1
|
[NCBI]
|
8.34065e-06
|
|
|
RETN
|
[NCBI]
|
8.34065e-06
|
|
|
MTHFR
|
[NCBI]
|
8.17999e-06
|
|
|
ADRB2
|
[NCBI]
|
7.92078e-06
|
|
|
PI
|
[NCBI]
|
7.46213e-06
|
|
|
ALGS1
|
[NCBI]
|
7.45237e-06
|
|
|
APOB
|
[NCBI]
|
7.29992e-06
|
|
|
EMD
|
[NCBI]
|
7.15713e-06
|
|
|
LEPR
|
[NCBI]
|
6.90046e-06
|
|
|
TNFRSF1B
|
[NCBI]
|
6.80869e-06
|
|
|
SRF
|
[NCBI]
|
6.73348e-06
|
|
|
HGPS
|
[NCBI]
|
6.55731e-06
|
|
|
IBD1
|
[NCBI]
|
6.41855e-06
|
|
|
SLS
|
[NCBI]
|
5.89056e-06
|
|
|
PTHLH
|
[NCBI]
|
5.6882e-06
|
|
|
AKT1
|
[NCBI]
|
5.59616e-06
|
|
|
ALB
|
[NCBI]
|
5.56468e-06
|
|
|
PXE
|
[NCBI]
|
5.43807e-06
|
|
|
FGF1
|
[NCBI]
|
5.33147e-06
|
|
|
ENPP1
|
[NCBI]
|
5.07995e-06
|
|
|
PRL
|
[NCBI]
|
5.01056e-06
|
|
|
CRH
|
[NCBI]
|
5.00777e-06
|
|
|
EDNRB
|
[NCBI]
|
4.84067e-06
|
|
|
GHRH
|
[NCBI]
|
4.75814e-06
|
|
|
LTA
|
[NCBI]
|
4.61283e-06
|
|
|
NFKB1
|
[NCBI]
|
4.39568e-06
|
|
|
DDC
|
[NCBI]
|
4.39568e-06
|
|
|
FSHR
|
[NCBI]
|
4.39568e-06
|
|
|
VASP
|
[NCBI]
|
4.39568e-06
|
|
|
LMNA
|
[NCBI]
|
4.04795e-06
|
|
|
APOD
|
[NCBI]
|
3.99086e-06
|
|
|
AHO
|
[NCBI]
|
3.87219e-06
|
|
|
ADIPOQ
|
[NCBI]
|
3.80203e-06
|
|
|
SLC18A3
|
[NCBI]
|
3.80203e-06
|
|
|
CNTF
|
[NCBI]
|
3.62645e-06
|
|
|
TFPI
|
[NCBI]
|
3.61452e-06
|
|
|
LOX
|
[NCBI]
|
3.44896e-06
|
|
|
NF1
|
[NCBI]
|
3.40435e-06
|
|
|
PON1
|
[NCBI]
|
3.34479e-06
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
3.28384e-06
|
|
|
UMOD
|
[NCBI]
|
3.28384e-06
|
|
|
F2R
|
[NCBI]
|
3.1258e-06
|
|
|
coproporphyria
|
[NCBI]
|
3.1258e-06
|
|
|
SLC6A3
|
[NCBI]
|
3.11372e-06
|
|
|
CDK2
|
[NCBI]
|
3.07351e-06
|
|
|
HGF
|
[NCBI]
|
3.02024e-06
|
|
|
INSR
|
[NCBI]
|
2.98681e-06
|
|
|
NOD2
|
[NCBI]
|
2.97446e-06
|
|
|
APCS
|
[NCBI]
|
2.8295e-06
|
|
|
FRDA
|
[NCBI]
|
2.58304e-06
|
|
|
fabry disease
|
[NCBI]
|
2.45628e-06
|
|
|
TCF7L2
|
[NCBI]
|
2.30751e-06
|
|
|
VIP
|
[NCBI]
|
2.21588e-06
|
|
|
PKD1
|
[NCBI]
|
2.21376e-06
|
|
|
IAPP
|
[NCBI]
|
2.10353e-06
|
|
|
SHBG
|
[NCBI]
|
1.78175e-06
|
|
|
APOA1
|
[NCBI]
|
1.58032e-06
|
|
|
FGF2
|
[NCBI]
|
1.58032e-06
|
|
|
GPT
|
[NCBI]
|
1.40875e-06
|
|
|
LEP
|
[NCBI]
|
1.37975e-06
|
|
|
BWS
|
[NCBI]
|
1.2688e-06
|
|
|
GH1
|
[NCBI]
|
1.25109e-06
|
|
|
PKD2
|
[NCBI]
|
1.25109e-06
|
|
|
B2M
|
[NCBI]
|
1.17716e-06
|
|
|
GIP
|
[NCBI]
|
1.04761e-06
|
|
|
HNF1A
|
[NCBI]
|
9.73649e-07
|
|
|
UCN
|
[NCBI]
|
9.73649e-07
|
|
|
OXT
|
[NCBI]
|
9.73649e-07
|
|
|
MAP3K5
|
[NCBI]
|
9.73649e-07
|
|
|
ELN
|
[NCBI]
|
9.73649e-07
|
|
|
PLG
|
[NCBI]
|
9.61497e-07
|
|
|
ABCC8
|
[NCBI]
|
8.52189e-07
|
|
|
APOE
|
[NCBI]
|
7.55993e-07
|
|
|
TS
|
[NCBI]
|
6.93399e-07
|
|
|
FGFR2
|
[NCBI]
|
6.37853e-07
|
|
|
ADCYAP1
|
[NCBI]
|
5.7948e-07
|
|
|
MAP2
|
[NCBI]
|
3.93503e-07
|
|
|
SLC2A4
|
[NCBI]
|
3.90514e-07
|
|
|
UCP1
|
[NCBI]
|
3.90514e-07
|
|
|
LDLR
|
[NCBI]
|
3.14268e-07
|
|
|
MB
|
[NCBI]
|
3.00926e-07
|
|
|
GHR
|
[NCBI]
|
3.00926e-07
|
|
|
NGFB
|
[NCBI]
|
2.88448e-07
|
|
|
CP
|
[NCBI]
|
2.5157e-07
|
|
|
MFS
|
[NCBI]
|
1.84813e-07
|
|
|
CHAT
|
[NCBI]
|
1.49894e-07
|
|
|
GCK
|
[NCBI]
|
1.44412e-07
|
|
|
BCHE
|
[NCBI]
|
1.3323e-07
|
|
|
GNAS
|
[NCBI]
|
1.25297e-07
|
|
|
SPP1
|
[NCBI]
|
1.14998e-07
|
|
|
SLC6A4
|
[NCBI]
|
5.1481e-08
|
|
|
KDR
|
[NCBI]
|
4.64182e-08
|
|
|
EPOR
|
[NCBI]
|
3.14873e-08
|
|
|
SERPINA6
|
[NCBI]
|
2.23036e-08
|
|
|
SOD2
|
[NCBI]
|
1.0471e-08
|
|
|
SLOS
|
[NCBI]
|
1.97634e-09
|
|